Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma
Condition:   Synovial Sarcoma Interventions:   Biological: TBI-1301;   Drug: Cyclophosphamide Sponsor:   Takara Bio Inc. Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2017 Category: Research Source Type: clinical trials